Our professionals
Dr. Jaime Gállego
Neurology Specialist.
Preferred focus on the study and treatment of primary brain tumors, paraneoplastic neurological syndromes and other neurological complications of cancer, multiple sclerosis, and autoimmune neurological diseases.
Professional career
Medical Degree, Universidad de Navarra (2003). PhD in Medicine, Universidad de Navarra (2013).
Neurology Specialist at Clínica Universidad de Navarra (2008). Clinical Research Fellow in Neuro-Oncology at Hôpital La Salpêtrière (Paris), under the supervision of Professor Jean-Yves Delattre (2009–2011). Diploma in Neuro-Oncology, Université Pierre et Marie Curie (Paris, 2010–2012).
Specialist, Department of Neurology, Clínica Universidad de Navarra, and Coordinator of the Neuro-Oncology Area.
RESEARCH AREAS
Member of the Brain Tumor Group at the Instituto de Investigación Sanitaria de Navarra (IdiSNA).
He has led several clinical trials as principal investigator and has collaborated on more than 10 clinical trials/research projects.
AREAS OF INTEREST
Study of the diagnosis and treatment of primary brain tumors.
Study of the treatment of glioblastoma in older patients. Research on blood biomarkers for brain tumors.
Study and treatment of multiple sclerosis and immune-mediated diseases.
Activity
In teaching
Clinical Associate Professor, Faculty of Medicine, Universidad de Navarra.
In research
He has authored more than 60 presentations/communications for national and international conferences and has contributed to more than 45 national and international books and journals.

Awards and recognitions
- European Association of Neuro-oncology Best Research of the Year Award.
Scientific organizations
- Full member of the Spanish Society of Neurology (SEN), Coordinator of the Neuro-Oncology Study Group.
- Member of the Navarre Society of Neurology.
- Member of the Spanish Group of Research in Neuro-Oncology (GEINO).
- Member of the European Association of Neuro-Oncology (EANO).
- Member of the Brain Tumor Group of the European Organisation for Research and Treatment of Cancer.